Fruehwirt, Wolfgang, Cobb, Adam D., Mairhofer, Martin, Weydemann, Leonard, Garn, Heinrich, Schmidt, Reinhold, Benke, Thomas, Dal-Bianco, Peter, Ransmayr, Gerhard, Waser, Markus, Grossegger, Dieter, Zhang, Pengfei, Dorffner, Georg, Roberts, Stephen
As societies around the world are ageing, the number of Alzheimer's disease (AD) patients is rapidly increasing. To date, no low-cost, non-invasive biomarkers have been established to advance the objectivization of AD diagnosis and progression assessment. Here, we utilize Bayesian neural networks to develop a multivariate predictor for AD severity using a wide range of quantitative EEG (QEEG) markers. The Bayesian treatment of neural networks both automatically controls model complexity and provides a predictive distribution over the target function, giving uncertainty bounds for our regression task. It is therefore well suited to clinical neuroscience, where data sets are typically sparse and practitioners require a precise assessment of the predictive uncertainty. We use data of one of the largest prospective AD EEG trials ever conducted to demonstrate the potential of Bayesian deep learning in this domain, while comparing two distinct Bayesian neural network approaches, i.e., Monte Carlo dropout and Hamiltonian Monte Carlo.
Although convolutional neural networks (CNNs) currently dominate competitions on image segmentation, for neuroimaging analysis tasks, more classical generative approaches based on mixture models are still used in practice to parcellate brains. To bridge the gap between the two, in this paper we propose a marriage between a probabilistic generative model, which has been shown to be robust to variability among magnetic resonance (MR) images acquired via different imaging protocols, and a CNN. The link is in the prior distribution over the unknown tissue classes, which are classically modelled using a Markov random field. In this work we model the interactions among neighbouring pixels by a type of recurrent CNN, which can encode more complex spatial interactions. We validate our proposed model on publicly available MR data, from different centres, and show that it generalises across imaging protocols. This result demonstrates a successful and principled inclusion of a CNN in a generative model, which in turn could be adapted by any probabilistic generative approach for image segmentation.
Artificial intelligence is enabling many scientific breakthroughs, especially in fields of study that generate high volumes of complex data such as neuroscience. As impossible as it may seem, neuroscientists are making strides in decoding neural activity into speech using artificial neural networks. Yesterday, the neuroscience team of Gopala K. Anumanchipalli, Josh Chartier, and Edward F. Chang of University of California San Francisco (UCSF) published in Nature their study using artificial intelligence and a state-of-the-art brain-machine interface to produce synthetic speech from brain recordings. The concept is relatively straightforward--record the brain activity and audio of participants while they are reading aloud in order to create a system that decodes brain signals for vocal tract movements, then synthesize speech from the decoded movements. The execution of the concept required sophisticated finessing of cutting-edge AI techniques and tools.
Parkinson's disease patients develop different speech impairments that affect their communication capabilities. The automatic assessment of the speech of the patients allows the development of computer aided tools to support the diagnosis and the evaluation of the disease severity. This paper introduces a methodology to classify Parkinson's disease from speech in three different languages: Spanish, German, and Czech. The proposed approach considers convolutional neural networks trained with time frequency representations and a transfer learning strategy among the three languages. The transfer learning scheme aims to improve the accuracy of the models when the weights of the neural network are initialized with utterances from a different language than the used for the test set. The results suggest that the proposed strategy improves the accuracy of the models in up to 8\% when the base model used to initialize the weights of the classifier is robust enough. In addition, the results obtained after the transfer learning are in most cases more balanced in terms of specificity-sensitivity than those trained without the transfer learning strategy.
IBM said on Thursday it will spend $240 million over the next decade to fund a new artificial intelligence research lab at the Massachusetts Institute of Technology. The resulting MIT–IBM Watson AI Lab will focus on a handful of key AI areas including the development of new "deep learning" algorithms. Deep learning is a subset of AI that aims to bring human-like learning capabilities to computers so they can operate more autonomously. The Cambridge, Mass.-based lab will be led by Dario Gil, vice president of AI for IBM Research and Anantha Chandrakasan, dean of MIT's engineering school. It will draw upon about 100 researchers from IBM (ibm) itself and the university.